Review



2 chloro n 6 cyclopentyladenosine ccpa  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Tocris 2 chloro n 6 cyclopentyladenosine ccpa
    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.
    2 Chloro N 6 Cyclopentyladenosine Ccpa, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/2-Chloro-N6-cyclopentyladenosine/pmc13004594-32-4-10
    Average 93 stars, based on 78 article reviews
    2 chloro n 6 cyclopentyladenosine ccpa - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Specific GPCRs elicit unique extracellular vesicle miRNA array signatures"

    Article Title: Specific GPCRs elicit unique extracellular vesicle miRNA array signatures

    Journal: eLife

    doi: 10.7554/eLife.107865

    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.
    Figure Legend Snippet: ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.

    Techniques Used: Activation Assay, Inhibition, Activity Assay, Control

    U2OS cells were incubated with VC or a selective agonist 2-chloro- N 6 -cyclopentyladenosine (CCPA) ( A ), 2-pyridylethylamine dihydrochloride (PEA) ( B ), Wnt3a ( C ), or SDF-1α ( D ) for ADORA1, HRH1, FZD4, and ACKR3, respectively. EVs were isolated, and the concentration was normalized as a percentage of the media control (MC). EV size distribution following agonist or VC treatment in ADORA1 ( E ), HRH1 ( F ), FZD4 ( G ), and ACKR3 ( H ). Data are shown as mean ± SEM, n=3. A t-test determined no significant differences in EV concentration or size distribution between the VC and agonist stimulation in all G protein-coupled receptors (GPCRs), p>0.05.
    Figure Legend Snippet: U2OS cells were incubated with VC or a selective agonist 2-chloro- N 6 -cyclopentyladenosine (CCPA) ( A ), 2-pyridylethylamine dihydrochloride (PEA) ( B ), Wnt3a ( C ), or SDF-1α ( D ) for ADORA1, HRH1, FZD4, and ACKR3, respectively. EVs were isolated, and the concentration was normalized as a percentage of the media control (MC). EV size distribution following agonist or VC treatment in ADORA1 ( E ), HRH1 ( F ), FZD4 ( G ), and ACKR3 ( H ). Data are shown as mean ± SEM, n=3. A t-test determined no significant differences in EV concentration or size distribution between the VC and agonist stimulation in all G protein-coupled receptors (GPCRs), p>0.05.

    Techniques Used: Incubation, Isolation, Concentration Assay, Control

    Related Articles

    other:

    Article Title: Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons
    Article Snippet: 4,5,6,7-Tetrahydroisoxazolo[5,4- c ]pyridin-3-ol hydrochloride (THIP, also known as gaboxadol, Tocris, hydrochloride), 4-chloro- N -[2-(2-thienyl)imidazo[1,2- a ]pyridin-3-yl]]benzamide (DS2, Tocris), bicuculline (Tocris), and picrotoxin (Sigma-Aldrich) were used to measure the tonic current.

    Article Title: A pharmacological characterization of GABA, THIP and DS2 at binary α4β3 and β3δ receptors: GABA activates β3δ receptors via the β3(+)δ(-) interface.
    Article Snippet: There is growing evidence that GABA (γ-aminobutyric acid) can activate GABAA receptors (GABAARs) in the absence of an α subunit.. In this study, we compared the pharmacology of homomeric and binary α4, β3 or δ subunits with ternary α4β3δ to identify subunit interfaces that contribute to the pharmacology of GABA, THIP, and DS2, and the antagonists, Zn 2+ , gabazine and bicuculline. β3δ receptors form functional GABA-gated channels when

    Article Title: Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons
    Article Snippet: 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride (THIP, also known as gaboxadol, Tocris, hydrochloride), 4-chloro-N-[2-(2thienyl)imidazo[1,2-a]pyridin-3-yl]]benzamide (DS2, Tocris), bicuculline (Tocris), and picrotoxin (Sigma-Aldrich) were used to measure the tonic current.

    Article Title: Synaptic GABA A Receptor Clustering without the γ2 Subunit
    Article Snippet: For pharmacological experiments, the perfusion solution was changed to one containing ACSF, 5 or 50 μ m flurazepam, 1 or 10 μ m ZnCl 2 , 100 n m 5α-Pregnane-3α,21-diol-20-one (THDOC), 10 μ m 4-chloro- N -[2-(2-thienyl)imidazo[1,2- a ]pyridin-3-yl]benzamide (DS2; Tocris Bioscience), 20 μ m tracazolate hydrochloride (Tocris Bioscience) or 10 μ m 4-ethyl-6,7-dimethoxy-9 H -pyrido[3,4- b ]indole-3-carboxylic acid methyl ester hydrochloride (DMCM hydrochloride; Tocris Bioscience).

    Article Title: Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons
    Article Snippet: GABA A R-mediated inhibitory postsynaptic currents (IPSCs) and tonic currents were isolated with the following agents in bath solution: 6-cyano-7-nitroquinoxaline-2,3-dione (10 μ m , Tocris, Minneapolis, MN, disodium salt), an AMPA receptor antagonist; DL-2-amino-5-phosphonopentanoic acid (10 μ m , Tocris, sodium salt), an NMDA receptor antagonist; and strychnine (1 μ m , Sigma-Aldrich, St. Louis, MO), a glycine receptor antagonist.

    Activity Assay:

    Article Title: Enhanced Thalamic Spillover Inhibition during Non–rapid-eye-movement Sleep Triggers an Electrocortical Signature of Anesthetic Hypnosis
    Article Snippet: Anesthesiology, V 125 • No 5 964 November 2016 T he electrocortical patterns that signal anestheticinduced loss of consciousness are only starting to be understood.1 There is an established link between increased frontal α-β frequency cortical activity and the onset of the behavioral correlates that mark loss of consciousness with γ-aminobutyric acid receptor type A (GABAAR)–targeting general anesthetic agents.2–4 Moreover, a critical role for the thalamus has been implicated in orchestrating the emergence of this α-β frequency electrocortical signature during the induction of anesthesia.1,3–5 Specifically, in vivo local field potential recordings in rodents identify that during propofol-induced loss of consciousness, elevated α-β activity in the thalamus precedes manifestation of the same signature in the cortex.4 Additionally, computational modeling indicates that increased γ-aminobutyric acid–mediated (GABAergic) conductance and prolonged inhibitory postsynaptic potentials (IPSPs) in thalamocortical neurons can reinforce cortical activity in the α-β frequency range.3,5 Importantly, the molecular and cellular underpinnings that could position the thalamus to orchestrate these electrocortical changes remain to be elucidated in vivo.. What We Already Know about This Topic



    Similar Products

    93
    Thermo Fisher dimethylacetamide dmac
    Dimethylacetamide Dmac, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/2-chloro-N%2CN-dimethylacetamide%2C+97%25/10__1016_slash_j__microc__2025__116106-45-3-17
    Average 93 stars, based on 1 article reviews
    dimethylacetamide dmac - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Thermo Fisher 6 chlorobenzotriazole 1 yl 1 1 3 3 tetramethyluronium hexafluorophosphate hctu
    6 Chlorobenzotriazole 1 Yl 1 1 3 3 Tetramethyluronium Hexafluorophosphate Hctu, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/O-(6-Chloro-1H-benzotriazol-1-yl)-N%2CN%2CN'%2CN'-tetramethyluronium+hexafluorophosphate%2C+98%2B%25/pmc13175576-387-23-39
    Average 94 stars, based on 1 article reviews
    6 chlorobenzotriazole 1 yl 1 1 3 3 tetramethyluronium hexafluorophosphate hctu - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Bristol Myers bms 289948 4 chloro n 2 5 difluorophenyl n
    Bms 289948 4 Chloro N 2 5 Difluorophenyl N, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/1+1h+2+2+289948+3+4+4+5+benzenesulfonamide+bms+chloro+difluorophenyl+ethyl+fluoro+imidazol+ir+n+n+phenyl+propyl+yl/us12624118-2660-158-165
    Average 86 stars, based on 1 article reviews
    bms 289948 4 chloro n 2 5 difluorophenyl n - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Tocris 2 chloro n 6 cyclopentyladenosine ccpa
    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.
    2 Chloro N 6 Cyclopentyladenosine Ccpa, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/2-Chloro-N6-cyclopentyladenosine/pmc13004594-32-4-10
    Average 93 stars, based on 1 article reviews
    2 chloro n 6 cyclopentyladenosine ccpa - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology 4 2 oxo 2h chromen 3 yl 1 3 thiazol 2 yl thio acetic acid
    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.
    4 2 Oxo 2h Chromen 3 Yl 1 3 Thiazol 2 Yl Thio Acetic Acid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/(2Z)-6-Chloro-2-%5B(2%2C4-dimethoxyphenyl)imino%5D-N-(tetrahydrofuran-2-ylmethyl)-2H-chromene-3-carboxamide/us12576135-230-67-69
    Average 94 stars, based on 1 article reviews
    4 2 oxo 2h chromen 3 yl 1 3 thiazol 2 yl thio acetic acid - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology 2z 6 chloro 2
    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.
    2z 6 Chloro 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/GI+254023X/us12576135-230-61-62
    Average 91 stars, based on 1 article reviews
    2z 6 chloro 2 - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    95
    Tocris ht 2c r antagonist 6 chloro 5 methyl n
    Distribution <t>of</t> <t>5-HT</t> 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT <t>2C</t> <t>R</t> + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).
    Ht 2c R Antagonist 6 Chloro 5 Methyl N, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/SB+242084/pmc12963287-105-9-23
    Average 95 stars, based on 1 article reviews
    ht 2c r antagonist 6 chloro 5 methyl n - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    MedChemExpress 344 ctb n 4 chloro 3 trifluoromethyl phenyl 2 ethoxy benzamide
    Distribution <t>of</t> <t>5-HT</t> 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT <t>2C</t> <t>R</t> + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).
    344 Ctb N 4 Chloro 3 Trifluoromethyl Phenyl 2 Ethoxy Benzamide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/Benzamide/pm41707981-158-39-47
    Average 94 stars, based on 1 article reviews
    344 ctb n 4 chloro 3 trifluoromethyl phenyl 2 ethoxy benzamide - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Protox Therapeutics saflufenacil 2 chloro 4 fluoro 5 3 methyl 2 6 dioxo 4 trifuoromethyl pyrimidin 1 yl n
    Distribution <t>of</t> <t>5-HT</t> 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT <t>2C</t> <t>R</t> + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).
    Saflufenacil 2 Chloro 4 Fluoro 5 3 Methyl 2 6 Dioxo 4 Trifuoromethyl Pyrimidin 1 Yl N, supplied by Protox Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/1+2+2+3+4+4+5+6+benzamide+chloro+dioxo+fluoro+methyl+methyl+n+propane2+pyrimidin+saflufenacil+sulfamoyl+trifuoromethyl+yl+yl/pm41238669-47-0-11
    Average 86 stars, based on 1 article reviews
    saflufenacil 2 chloro 4 fluoro 5 3 methyl 2 6 dioxo 4 trifuoromethyl pyrimidin 1 yl n - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Tokyo Chemical Industry chloro 1 n octanol
    Distribution <t>of</t> <t>5-HT</t> 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT <t>2C</t> <t>R</t> + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).
    Chloro 1 N Octanol, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chloro+n/1+2+chloro+iodide+methylpyridinium/pm41172971-42-4-8
    Average 86 stars, based on 1 article reviews
    chloro 1 n octanol - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.

    Journal: eLife

    Article Title: Specific GPCRs elicit unique extracellular vesicle miRNA array signatures

    doi: 10.7554/eLife.107865

    Figure Lengend Snippet: ( A ) Dose-dependent cAMP accumulation after ADORA1 activation with agonist, 2-chloro- N 6 -cyclopentyladenosine (CCPA), or inhibition with antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (5 μM). ( B ) Dose-dependent IP1 accumulation after 2-pyridylethylamine dihydrochloride (PEA) stimulation of histamine receptor H1 (HRH1) and inhibition by cetirizine (1 μM). ( C ) Alkaline phosphatase (ALP) activity after stimulation of frizzled class receptor 4 (FZD4) by Wnt3a. ( D ) The ratio of phosphorylated ERK1/2 (pERK1/2) by total ERK 1/2 (tERK1/2) after stimulation of ACKR3 by SDF-1α. For all graphs, data are shown as mean ± SD, with n=3 independent repeats, each having duplicate determinants, ns = not significant, *p<0.05, **p<0.01, ***p<0.001 vs. vehicle control (VC). Statistical significances were determined by one-way or two-way ANOVA of receptors by agonists or antagonists and post hoc Tukey’s or Sidak’s testing for multiple comparisons.

    Article Snippet: Chemical compound, drug , 2-Chloro- N 6 -cyclopentyladenosine (CCPA) , Tocris Bioscience , 1705 CAS:37739-05-2 , .

    Techniques: Activation Assay, Inhibition, Activity Assay, Control

    U2OS cells were incubated with VC or a selective agonist 2-chloro- N 6 -cyclopentyladenosine (CCPA) ( A ), 2-pyridylethylamine dihydrochloride (PEA) ( B ), Wnt3a ( C ), or SDF-1α ( D ) for ADORA1, HRH1, FZD4, and ACKR3, respectively. EVs were isolated, and the concentration was normalized as a percentage of the media control (MC). EV size distribution following agonist or VC treatment in ADORA1 ( E ), HRH1 ( F ), FZD4 ( G ), and ACKR3 ( H ). Data are shown as mean ± SEM, n=3. A t-test determined no significant differences in EV concentration or size distribution between the VC and agonist stimulation in all G protein-coupled receptors (GPCRs), p>0.05.

    Journal: eLife

    Article Title: Specific GPCRs elicit unique extracellular vesicle miRNA array signatures

    doi: 10.7554/eLife.107865

    Figure Lengend Snippet: U2OS cells were incubated with VC or a selective agonist 2-chloro- N 6 -cyclopentyladenosine (CCPA) ( A ), 2-pyridylethylamine dihydrochloride (PEA) ( B ), Wnt3a ( C ), or SDF-1α ( D ) for ADORA1, HRH1, FZD4, and ACKR3, respectively. EVs were isolated, and the concentration was normalized as a percentage of the media control (MC). EV size distribution following agonist or VC treatment in ADORA1 ( E ), HRH1 ( F ), FZD4 ( G ), and ACKR3 ( H ). Data are shown as mean ± SEM, n=3. A t-test determined no significant differences in EV concentration or size distribution between the VC and agonist stimulation in all G protein-coupled receptors (GPCRs), p>0.05.

    Article Snippet: Chemical compound, drug , 2-Chloro- N 6 -cyclopentyladenosine (CCPA) , Tocris Bioscience , 1705 CAS:37739-05-2 , .

    Techniques: Incubation, Isolation, Concentration Assay, Control

    Distribution of 5-HT 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT 2C R + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).

    Journal: Frontiers in Pharmacology

    Article Title: Thalamic distribution and effects of 5-HT2C receptors on tonic GABAA inhibition and absence seizures: implications for treatment

    doi: 10.3389/fphar.2026.1729460

    Figure Lengend Snippet: Distribution of 5-HT 2C Rs in the VB and NRT. Brightfield photomicrographs showing the distribution of 5-HT 2C receptor immunoreactivity in the VB and NRT (A,D,G) , and enlarged sections of the NRT (B,E,H) and VB (C,F,I) of P25-30 NEC, GAERS and Wistar rats, as indicated. (J,K) Quantification of 5-HT 2C R + neuron density in the NRT and VB of the three strains. No significant differences were observed in the NRT. In the VB, Wistar rats displayed a significantly higher 5-HT 2C R + neuron density than NEC and GAERS ( P < 0.05), with GAERS showing the lowest count ( P < 0.05). Scale bar = 200 µm in (G) (applies to (A,D,G) ) and = 50 µm in (I) (applies to (B,C,E,F,H,I) ). One-Way ANOVA with Tukey’s multiple post-test comparison (* P < 0.05).

    Article Snippet: The 5-HT 2C R agonist (2S)-1-(6-chloro-5-fluoroindol-1-yl)propan-2-amine (Ro 60-0175), the 5-HT 2C R antagonist 6-chloro-5-methyl-N-(6-(2-methylpyridin-3-yl)oxypyridin-3-yl)-2 (SB242084) and gabazine (SR 95531 hydrobromide) were purchased from Tocris Bioscience (United Kingdom).

    Techniques: Comparison